Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
12,317
Total Claims
$1.0M
Drug Cost
791
Beneficiaries
$1,280
Cost/Patient
Risk Score Breakdown 21/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
+60%
Opioid rate vs peers
4.1% vs 2.6% avg
+20%
Cost per patient vs peers
$1,280 vs $1,068 avg
+10%
Brand preference vs peers
9.9% vs 9.0% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
4.1%
Opioid Rate
508
Opioid Claims
$22K
Opioid Cost
13.4%
Long-Acting Rate
Brand vs Generic
Brand: 1,207 claims · $798K
Generic: 11,022 claims · $211K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 203 | $172K |
| Dulaglutide | 46 | $63K |
| Semaglutide | 47 | $60K |
| Linagliptin | 33 | $47K |
| Insulin Glargine,hum.Rec.Anlog | 30 | $36K |
| Rivaroxaban | 32 | $34K |
| Fluticasone/Umeclidin/Vilanter | 35 | $30K |
| Empagliflozin | 22 | $26K |
| Levothyroxine Sodium | 493 | $17K |
| Insulin Glargine-Yfgn | 33 | $17K |
| Insulin Glargine-Yfgn | 22 | $17K |
| Semaglutide | 15 | $16K |
| Fluticasone/Vilanterol | 36 | $16K |
| Sacubitril/Valsartan | 19 | $14K |
| Atorvastatin Calcium | 615 | $8,117 |
Prescribing Profile
Patient Profile
77
Avg Age
53%
Female
1.43
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About